JP2023532248A5 - - Google Patents
Info
- Publication number
- JP2023532248A5 JP2023532248A5 JP2022579851A JP2022579851A JP2023532248A5 JP 2023532248 A5 JP2023532248 A5 JP 2023532248A5 JP 2022579851 A JP2022579851 A JP 2022579851A JP 2022579851 A JP2022579851 A JP 2022579851A JP 2023532248 A5 JP2023532248 A5 JP 2023532248A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- antibody
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/098133 | 2020-06-24 | ||
| PCT/CN2020/098133 WO2021258337A1 (en) | 2020-06-24 | 2020-06-24 | Human monoclonal antibodies against tigit for immune related diseases |
| PCT/CN2021/101901 WO2021259335A1 (en) | 2020-06-24 | 2021-06-23 | Human monoclonal antibodies against tigit for immune related diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023532248A JP2023532248A (ja) | 2023-07-27 |
| JP2023532248A5 true JP2023532248A5 (https=) | 2024-06-06 |
Family
ID=79281998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579851A Pending JP2023532248A (ja) | 2020-06-24 | 2021-06-23 | 免疫関連疾患のためのｔｉｇｉｔに対するヒトモノクローナル抗体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12606619B2 (https=) |
| EP (1) | EP4172209A4 (https=) |
| JP (1) | JP2023532248A (https=) |
| CN (1) | CN116670286A (https=) |
| WO (2) | WO2021258337A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4320160A1 (en) * | 2021-04-09 | 2024-02-14 | Seagen Inc. | Methods of treating cancer with anti-tigit antibodies |
| CN115043910B (zh) * | 2022-03-25 | 2023-04-07 | 湖南中晟全肽生化有限公司 | 抑制tigit与cd155结合的多肽及其应用 |
| WO2025255297A1 (en) * | 2024-06-05 | 2025-12-11 | Agilent Technologies, Inc. | Anti-human tigit antibodies for in vitro diagnostics |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4733C1 (ro) | 2014-08-19 | 2021-07-31 | Merck Sharp & Dohme Corp | Anticorpi anti-TIGIT |
| TWI715587B (zh) * | 2015-05-28 | 2021-01-11 | 美商安可美德藥物股份有限公司 | Ｔｉｇｉｔ結合劑和彼之用途 |
| CN108290936B (zh) * | 2015-08-14 | 2022-07-12 | 默沙东公司 | 抗tigit抗体 |
| EP3589313A4 (en) * | 2017-02-28 | 2021-05-19 | Seagen Inc. | ANTI-TIGITE ANTIBODY |
| IL272227B2 (en) * | 2017-07-27 | 2025-09-01 | iTeos Belgium SA | Anti-tigit antibodies |
| CN109384846B (zh) * | 2018-09-25 | 2020-03-03 | 合肥瑞达免疫药物研究所有限公司 | 能够结合tigit的抗体或其抗原结合片段及用途 |
| CN111196852A (zh) * | 2018-11-16 | 2020-05-26 | 四川科伦博泰生物医药股份有限公司 | 抗tigit抗体及其用途 |
| CN109734806B (zh) | 2019-03-15 | 2022-07-01 | 安徽安科生物工程（集团）股份有限公司 | 一种全人源抗huTIGIT单克隆抗体及其应用 |
-
2020
- 2020-06-24 WO PCT/CN2020/098133 patent/WO2021258337A1/en not_active Ceased
-
2021
- 2021-06-23 EP EP21829075.7A patent/EP4172209A4/en active Pending
- 2021-06-23 WO PCT/CN2021/101901 patent/WO2021259335A1/en not_active Ceased
- 2021-06-23 US US18/145,309 patent/US12606619B2/en active Active
- 2021-06-23 CN CN202180052207.1A patent/CN116670286A/zh active Pending
- 2021-06-23 JP JP2022579851A patent/JP2023532248A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018035138A5 (https=) | ||
| JP2021529557A5 (https=) | ||
| JP2024056938A5 (https=) | ||
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| JP2021524249A5 (https=) | ||
| JP2021531005A5 (https=) | ||
| JP2021524244A5 (https=) | ||
| JP2022533538A5 (https=) | ||
| JP2020528768A5 (https=) | ||
| CN112135626A (zh) | 抗tigit抗体及其用途 | |
| HRP20200583T1 (hr) | Protutijela koja neutraliziraju gp120 i njihova upotreba | |
| JP2021524256A5 (https=) | ||
| JP2015533853A5 (https=) | ||
| JP2023532248A5 (https=) | ||
| RU2013125459A (ru) | АНТИТЕЛА ПРОТИВ БЕЛКА РЕЦЕПТОРА c-Met | |
| JP2024540148A5 (https=) | ||
| JP2021510736A5 (https=) | ||
| JP2023093753A5 (https=) | ||
| JP2019516392A5 (https=) | ||
| CN112513094A (zh) | 结合人her2的抗体、其制备方法和用途 | |
| CN111712521A (zh) | Cd38蛋白抗体及其应用 | |
| JP2023545182A5 (https=) | ||
| JP2024024114A5 (https=) | ||
| JP2024516098A5 (https=) | ||
| JP2023545183A5 (https=) |